image: Researchers reveal how gut bacteria convert dietary phytosterols into sulfated metabolites that circulate in mice, accumulate in tissues with age, and are also detected in human plasma.
Credit: Prof. Makoto Arita from Keio University, Japan
Gut microbiome can transform dietary compounds in ways that extend their effects beyond the intestine. Researchers at Keio University found that gut bacteria convert dietary phytosterols into sulfated metabolites that circulate throughout the body. In mice, these compounds were detected in multiple tissues and showed age-dependent accumulation. The team also identified three phytosterol sulfates in human plasma, highlighting a previously underappreciated link between gut microbial activity and broader sterol metabolism.
Phytosterols are plant-derived compounds found in vegetable oils, nuts, and seeds. They are studied for their ability to reduce cholesterol absorption, yet only about 5% enter the circulation and most are excreted. How gut bacteria influence their metabolism and tissue distribution has remained unclear.
Addressing this challenge, the research team involving Professor Makoto Arita, Professor and Dean of the Faculty of Pharmacy, Assistant Professor Satoshi Morozumi, and Mr. Koki Tomita from the Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Japan, analyzed lipidomic datasets from specific pathogen-free (SPF), germ-free (GF), and antibiotic-treated (Abx) mice; screened ten representative Bacteroidota species for sitosterol sulfate (SIS) production; characterized bacterial sterol sulfotransferases (Sults); and compared the activity of the Bacteroides thetaiotaomicron Sult with mouse and human enzymes. They also investigated age-dependent changes in sterol sulfate levels using previously published mouse tissue lipidomics datasets and reanalyzed human plasma lipidomics data. The study was made available online on October 16, 2026, and will be published in Volume 29, Issue 11 of the journal iScience on November 20, 2026.
Fecal levels of SIS and stigmasterol sulfate fell by 98.2% and 99.2%, respectively, in GF mice compared with SPF mice. Campesterol sulfate and coprostanol sulfate decreased by 87.4% and 64.6%, respectively. These metabolites were also reduced in Abx mice, supporting their microbial origin. Six of the 10 Bacteroidota species screened—Parabacteroides goldsteinii, P. johnsonii, B. uniformis, B. fragilis, B. caccae, and B. thetaiotaomicron—were identified as SIS-producing bacteria, and their corresponding Sult homologs demonstrated functional sulfotransferase activity. The B. thetaiotaomicron enzyme showed greater phytosterol-sulfating activity than the mammalian enzymes tested and also acted on other phytosterol substrates. Relative SIS production was 51.6% for the bacterial enzyme, compared with 19.5% for the mouse enzyme and 11.4% for the human enzyme, when cholesterol sulfate production was normalized to 100%.
SIS was detected in nine mouse tissues, including the liver, kidney, and plasma, while unconjugated phytosterols were largely below the detection limit. SIS levels were more than twofold higher in mice with an intact microbiota than in GF mice. The researchers also found an age-related increase: SIS rose two- to fourfold in the bone marrow, kidney, liver, lung, plasma, and spleen. Campesterol sulfate and stigmasterol sulfate showed age-related increases in several organs as well. In human plasma lipidomic data, the team detected SIS, campesterol sulfate, and stigmasterol sulfate, providing evidence that these microbiota-associated metabolites also circulate in humans.
“Gut bacteria can convert dietary phytosterols, which are usually poorly absorbed, into sulfated metabolites that reach tissues beyond the intestine,” said Mr. Tomita.
“We first noticed signals of these compounds while studying the microbial metabolism of other sterols. Their detection in mouse tissues led us to investigate this pathway,” added Prof. Arita.
The findings suggest that gut microbial composition may influence the metabolites formed from dietary phytosterols, which are consumed for their cholesterol-lowering effects. However, the biological functions of phytosterol sulfates remain unknown, and the study does not establish whether their accumulation is beneficial or harmful. The precise mechanisms underlying their intestinal absorption, systemic distribution, and age-dependent accumulation also remain unclear. Further research must clarify their activity and possible relevance to age-related conditions.
Overall, the study identifies gut microbial sulfation as an important route of phytosterol metabolism and shows that the resulting compounds can be distributed throughout the body. By connecting microbial activity with tissue distribution and age-associated accumulation in mice, alongside detection in human plasma, the research provides a foundation for investigating the physiological significance of phytosterol sulfates.
***
Reference
DOI: 10.1016/j.isci.2026.117883
About Keio University Global Research Institute (KGRI), Japan
The Keio University Global Research Institute (KGRI), established in November 2016, serves as a university-wide platform connecting faculties and graduate schools. It promotes interdisciplinary and international collaborative research that transcends academic and geographic boundaries, while disseminating research outcomes both domestically and globally.
In 2024, Keio University launched the Program for Forming Japan’s Peak Research Universities (J-PEAKS), funded by the Japan Society for the Promotion of Science (JSPS), under the vision of becoming a “research university that forges the common sense of the future.” Through this initiative, KGRI is strengthening research infrastructure to enhance interdisciplinary collaboration, promoting the societal implementation of research, and fostering a research ecosystem that enables collaboration across the university and with leading institutions in Japan and abroad.
Website: https://www.keio.ac.jp/en/org/kgri/
About Bio2Q, Keio University
The Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) at Keio University is a research center that aims to investigate interactions between human biology and the microbiome using quantum computing and artificial intelligence. It seeks to explore previously uncharted areas of human biology and develop new approaches to treating intractable diseases. Keio University is the first private university to be selected for the World Premier International Research Center Initiative (WPI), promoted by Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT).
Website: https://bio2q.keio.ac.jp
About Professor Makoto Arita
Dr. Makoto Arita is a Professor and Dean of the Faculty of Pharmacy, Keio University, and Core Director of the Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q). His research focuses on lipid biology and lipidomics. Using advanced analytical technologies, he investigates the diversity, distribution, and functions of lipids in living systems to better understand biological processes and disease mechanisms.
About Koki Tomita from Keio University
Mr. Koki Tomita was a graduate student researcher at the Graduate School of Pharmaceutical Sciences, Keio University, Japan, at the time of this research. His work focuses on gut microbial sterol metabolism; particularly how intestinal bacteria transform dietary sterols into biologically relevant metabolites. His academic interests span microbiology, biochemistry, metabolomics, and lipidomics, bringing together approaches to understand interactions between the gut microbiome and host metabolism. He also studies microbial contributions to host physiology. In this study, his research contributed to identifying microbiota-derived phytosterol sulfates and examining their distribution in mouse tissues, age-associated changes, and presence in human plasma.
About Assistant Professor Satoshi Morozumi
Dr. Satoshi Morozumi is an Assistant Professor at the Faculty of Pharmacy, Keio University. His research focuses on gut microbiota-derived lipids. He aims to advance lipid-centric biology to uncover the interactions between gut microbiota and the host through mass spectrometry.
Funding information
This work was supported by the JST-ERATO “ARITA Lipidome Atlas Project” under grant number JPMJER2101 (M.A.), AMED Moonshot Research and Development Program JP22zf0127007 (M.A.), AMED NeDDTrim (21ae0121036 to M.A.), and World Premier International Research Center Initiative - Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q). This work was also supported by the Keio University Doctorate Student Grant-in-Aid Program (K.T.) and the Keio JST-SPRING program (K.T.).
Journal
iScience
Method of Research
Experimental study
Subject of Research
Animals
Article Title
Microbiome-dependent phytosterol sulfates production and tissue distribution in mice
Article Publication Date
20-Nov-2026
COI Statement
The authors declare no competing interests.